South Korea asked Vietnam to conduct a fair and objective probe into an anti-dumping case of its high-fructose corn syrup and for a discussion of “essential facts” before a final decision is made.
The investigation was prompted by a complaint filed by six Vietnamese sugar companies to the local authority that South Korea's “cheap” corn syrup products were hurting the domestic sugar industry and requested an anti-dumping duty of 40.02 percent be imposed.
According to South Korea's Ministry of Trade, Industry, and Energy, it held a video conference with Vietnam's Trade Remedy Authority of the Ministry of Industry and Trade to request an unbiased investigation.
The previous investigation was conducted from April 1, 2019, to March 31 this year.
In August, the Vietnamese authority sent questionnaires to Korean sugar firms with the answers being the basis for the conclusion.
Both countries agreed to implement trade restrictions based on transparent and fair investigation and guarantee the rights of companies, said an official from South Korea’s Trade Ministry.
The countries are eyeing a trading volume of $100 billion.
Vietnam currently imposes trade restrictions on South Korea's coated steel sheets, galvanized steel sheets, section shape steel, wires, and fertilizers.


Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
SK Hynix Shares Surge on Record $28.6 Billion Buyback
OpenAI Tightens AI Safety Monitoring After Security Incidents
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push 



